References
- Bodner, T. E. (2008), “What Improves With Increased Missing Data Imputations?,” Structural Equation Modeling, 15, 651–675. DOI: https://doi.org/10.1080/10705510802339072.
- Committee for Medicinal Products for Human Use (2010), “Guideline on Missing Data in Confirmatory Clinical Trials,” available at https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-missing-data-confirmatory-clinical-trials_en.pdf.
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2019), “ICH E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” available at https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf.
- Koehler, E., Brown, E., and Haneuse, S. J.-P. A. (2009), “On the Assessment of Monte Carlo Error in Simulation-Based Statistical Analyses,” The American Statistician, 63, 155–162. DOI: https://doi.org/10.1198/tast.2009.0030.
- Lu, K. (2017), “Number of Imputations Needed to Stabilize Estimated Treatment Difference in Longitudinal Data Analysis,” Statistical Methods in Medical Research, 26, 674–690. DOI: https://doi.org/10.1177/0962280214554439.
- Nassiri, V., Molenberghs, G., Verbeke, G., and Barbosa-Breda, J. (2020), “Iterative Multiple Imputation: A Framework to Determine the Number of Imputed Datasets,” The American Statistician, 74, 125–136, DOI: https://doi.org/10.1080/00031305.2018.1543615.
- National Research Council, Division of Behavioral and Social Sciences and Education, Committee on National Statistics, and Panel on Handling Missing Data in Clinical Trials (2010), The Prevention and Treatment of Missing Data in Clinical Trials, Washington, DC: National Academies Press.
- Nielsen, S. F. (2003), “Proper and Improper Multiple Imputation,” International Statistical Review, 71, 593–627. DOI: https://doi.org/10.1111/j.1751-5823.2003.tb00214.x.
- O’Kelly, M., and Ratitch, B. (2014), Clinical Trials With Missing Data: A Guide for Practitioners, Chichester: Wiley.
- Permutt, T. (2016), “Sensitivity Analysis for Missing Data in Regulatory Submissions,” Statistics in Medicine, 35, 2876–2879. DOI: https://doi.org/10.1002/sim.6753.
- Rezvan, P. H., Lee, K. J., and Simpson, J. A. (2015), “The Rise of Multiple Imputation: A Review of the Reporting and Implementation of the Method in Medical Research,” BMC Medical Research Methodology, 15, 30. DOI: https://doi.org/10.1186/s12874-015-0022-1.
- Royston, P. (2004), “Multiple Imputation of Missing Values,” The Stata Journal, 4, 227–241. DOI: https://doi.org/10.1177/1536867X0400400301.
- Rubin, D. B. (1987), Multiple Imputation for Nonresponse in Surveys, New York: Wiley.
- Russell-Jones, D., Bode, B. W., Block, C. D., Franek, E., Heller, S., Mathieu, C., Philis-Tsimikas, A., Rose, L., Woo, V., Østerskov, A., Graungaard, T., and Bergenstal, R. M. (2017), “Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1),” Diabetes Care, 40, 943–950. DOI: https://doi.org/10.2337/dc16-1771.
- van der Vaart, A. (1998), Asymptotic Statistics, New York: Cambridge University Press.
- White, I. R., Royston, P., and Wood, A. M. (2011), “Multiple Imputation Using Chained Equations: Issues and Guidance for Practice,” Statistics in Medicine, 30, 377–399. DOI: https://doi.org/10.1002/sim.4067.